Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Venatorx Pharmaceuticals, Inc.
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
1. Healthy adults 18-55 years
2. Males or non-pregnant, non-lactating females
3. Body mass index (BMI): ≥18 kg/m2 and ≤32.0 kg/m2, weight \>50.0 kg.
4. Must have negative alcohol, drug, or tobacco use/test and no use of alcohol, caffeine during the study
You may not be if
1. History or presence of current cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, autoimmune, hematologic, neoplastic, or neurological disorders
2. History of drug allergy or hypersensitivity to penicillin, cephalosporin, or beta-lactam antibacterial drug
3. Recent history of known or suspected Clostridioides difficile infection
4. Abnormal ECG or history of clinically significant abnormal rhythm disorder
5. Abnormal lab tests
Clareo Health | Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects